Cetuximab potentiates oxaliplatin cytotoxic effect through a defect in NER and DNA replication initiation

Documenti analoghi

• Trastuzumab induced in vivo tissue remodelling associated in vitro with inhibition of the active forms of AKT and PTEN and RhoB induction in an ovarian carcinoma model
  di: Delord, J-P, et al.
  Pubblicazione: (2010)
• Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells
  di: Temmink, O H, et al.
  Pubblicazione: (2007)
• Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer
  di: Jonker, D J, et al.
  Pubblicazione: (2014)
• Differential inhibition of trastuzumab- and cetuximab-induced cytotoxicity of cancer cells by immunoglobulin G1 expressing different GM allotypes
  di: Namboodiri, A M, et al.
  Pubblicazione: (2011)
• FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer
  di: Marzi, L, et al.
  Pubblicazione: (2016)